Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Conivaptan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 168626-94-6, Conivaptan hcl, Vaprisol, Ym 087, Conivaptan (hydrochloride), Ci-1025
    Molecular Formula
    C32H27ClN4O2
    Molecular Weight
    535.0  g/mol
    InChI Key
    BTYHAFSDANBVMJ-UHFFFAOYSA-N
    FDA UNII
    75L57R6X36
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide;hydrochloride
    2.1.2 InChI
    InChI=1S/C32H26N4O2.ClH/c1-21-33-28-19-20-36(29-14-8-7-13-27(29)30(28)34-21)32(38)23-15-17-24(18-16-23)35-31(37)26-12-6-5-11-25(26)22-9-3-2-4-10-22;/h2-18H,19-20H2,1H3,(H,33,34)(H,35,37);1H
    2.1.3 InChI Key
    BTYHAFSDANBVMJ-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6.Cl
    2.2 Other Identifiers
    2.2.1 UNII
    75L57R6X36
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. (1,1'-biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1h)-yl)carbonyl)phenyl)-

    2. (1,1'-biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1h)-yl)carbonyl)phenyl)-, Monohydrochloride

    3. 4''-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1h)-yl)carbonyl)-2-biphenylcarboxanilide

    4. Ci-1025

    5. Conivaptan

    6. Conivaptan Hcl

    7. Vaprisol

    8. Ym 087

    9. Ym-087

    10. Ym087

    2.3.2 Depositor-Supplied Synonyms

    1. 168626-94-6

    2. Conivaptan Hcl

    3. Vaprisol

    4. Ym 087

    5. Conivaptan (hydrochloride)

    6. Ci-1025

    7. Conivaptan Hydrochloride [usan]

    8. Ym-087

    9. N-[4-(2-methyl-4,5-dihydro-3h-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide Hydrochloride

    10. Ym087

    11. Conivaptan Hcl (vaprisol)

    12. 8626-94-6

    13. Chebi:31430

    14. 75l57r6x36

    15. (1,1'-biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1h)-yl)carbonyl)phenyl)-, Monohydrochloride

    16. [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1h)-yl)carbonyl]phenyl]-, Hydrochloride (1:1)

    17. 4'-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1h)-yl)carbonyl)-2-biphenylcarboxanilide Monohydrochloride

    18. N-(4-(2-methyl-1,4,5,6-tetrahydrobenzo[b]imidazo[4,5-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxamide Hydrochloride

    19. 4'-[(2-methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepin-6-yl)-carbonyl]-2-phenylbenzanilide Monohydrochloride

    20. N-[4-({4-methyl-3,5,9-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),2(6),4,10,12-pentaen-9-yl}carbonyl)phenyl]-2-phenylbenzamide Hydrochloride

    21. Smr004701209

    22. Unii-75l57r6x36

    23. Vaprisol (tn)

    24. Mls006010030

    25. Mls006010233

    26. Schembl387232

    27. Conivaptan Hcl [vandf]

    28. Chembl1201108

    29. Dtxsid70168585

    30. Vaprisol, Conivaptan Hydrochloride

    31. Bcp28426

    32. Ex-a1128

    33. Conivaptan Hydrochloride (jan/usan)

    34. Conivaptan Hydrochloride [mi]

    35. Hy-18347a

    36. Mfcd00945712

    37. Conivaptan Hydrochloride [jan]

    38. Akos015994583

    39. Akos025401635

    40. Ccg-269940

    41. Cs-2015

    42. Fe-0225

    43. Conivaptan Hydrochloride [mart.]

    44. Conivaptan Hydrochloride [who-dd]

    45. Ac-23918

    46. N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1h)-yl)carbonyl]phenyl]-[1,1'-biphenyl]-2-carboxamide Hydrochloride

    47. Db-064699

    48. Am20090724

    49. Ft-0657174

    50. Sw219215-1

    51. Conivaptan Hydrochloride [orange Book]

    52. D01236

    53. 626c946

    54. A810997

    55. J-010472

    56. Q27114306

    57. 4''-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1h)-yl)carbonyl)-2-biphenylcarboxanilide Monohydrochloride

    58. 4'-[(2-methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepin-6-yl)carbonyl]-2-phenylbenzanilide Hydrochloride

    59. N-(4-(2-methyl-1,4,5,6-tetrahydrobenzo[b]imidazo[4,5-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxamidehydrochloride

    60. N-[4-(2-methyl-4,5-dihydro-1h-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide;hydrochloride

    61. N-[4-(2-methyl-4,5-dihydro-3h-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide;hydrochloride

    62. N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1h)-yl)carbonyl]phenyl]-[1,1?-biphenyl]-2-carboxamide Hydrochloride

    63. N-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1h)-yl)carbonyl]phenyl}biphenyl-2-carboxamide Hydrochloride

    2.4 Create Date
    2005-06-24
    3 Chemical and Physical Properties
    Molecular Weight 535.0 g/mol
    Molecular Formula C32H27ClN4O2
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count3
    Rotatable Bond Count4
    Exact Mass534.1822538 g/mol
    Monoisotopic Mass534.1822538 g/mol
    Topological Polar Surface Area78.1 Ų
    Heavy Atom Count39
    Formal Charge0
    Complexity820
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameVaprisol
    PubMed HealthConivaptan (Injection)
    Drug ClassesEndocrine-Metabolic Agent
    Drug LabelConivaptan hydrochloride is chemically [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, monohydrochloride, having a molecular weight of 535.04 and molecular formula C32H26N4O2HCl. Th...
    Active IngredientConivaptan hydrochloride
    Dosage FormInjectable
    Routeinjection
    Strength20mg
    Market StatusPrescription
    CompanyAstellas

    2 of 2  
    Drug NameVaprisol
    PubMed HealthConivaptan (Injection)
    Drug ClassesEndocrine-Metabolic Agent
    Drug LabelConivaptan hydrochloride is chemically [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, monohydrochloride, having a molecular weight of 535.04 and molecular formula C32H26N4O2HCl. Th...
    Active IngredientConivaptan hydrochloride
    Dosage FormInjectable
    Routeinjection
    Strength20mg
    Market StatusPrescription
    CompanyAstellas

    5 Pharmacology and Biochemistry
    5.1 MeSH Pharmacological Classification

    Antidiuretic Hormone Receptor Antagonists

    Endogenous compounds and drugs that inhibit or block the activity of ANTIDUIRETIC HORMONE RECEPTORS. (See all compounds classified as Antidiuretic Hormone Receptor Antagonists.)